Any current/future new fundraising through debt or equity?

There is no mention of any new fundraising through debt or equity in the provided transcript. The company highlights a strong financial position, with current assets of INR187 crores against current liabilities of INR39 crores as of FY24. The INR70 crores expansion was fully funded through internal accruals, indicating no external fundraising. Bank limit utilization has decreased significantly from INR50.50 crores to INR19.43 crores by March 2024, showing reduced reliance on borrowings. For the upcoming Roha expansion, an estimated INR40-50 crores capex is expected, which will also be funded e

Future growth expectations in sales/revenue/volumes?

FY24 manufacturing volume stood at 3,800 metric tons; FY25 volume guidance is around 4,600-4,800 metric tons, indicating growth. By end of FY25, the run rate at full utilization is expected to be ~675 tons per month (vs current ~540 tons). Dahej SEZ plant capacity ramp-up to full utilization by Q3 FY25, contributing significantly to volumes and revenue. New high value, high margin products currently contributing ~15% of volume and potentially >30% of revenue, expected to grow. Expected average selling price per kilo to improve by more than 10% with new products and portfolio enhancemen

Future growth expectations in earnings/operating earnings/profits/EPS?

Company expects EBITDA margins to improve by another 400-600 basis points with full ramp-up of Dahej facility and new high-margin products. Manufacturing EBITDA margins have already improved by approx. 500 basis points from FY23 to FY24. Peak revenue potential from Dahej SEZ is INR250-300 crores. New products (high-value, high-margin) may contribute around 15% of volume but over 30% of revenue, boosting margins. Operating profits expected to rise as trading revenues decline and manufacturing revenues increase. By end of FY25, capacity utilization expected to reach 675 tons per month across all

Current/ Expected Orderbook/ Pending Orders?

The company has a strong order book with executable visibility going into FY '26. Existing order book allows full utilization of current and expanded production capacities, including the new Dahej SEZ plant. Additional approvals from very large accounts are at advanced stages, expected to be finalized in the coming months. Demand pipeline is robust, supporting confidence in ramping up capacity and pursuing a third expansion in Roha. The company is confident of meeting market demand and achieving full production utilization by end of FY '25, with an expected run rate of 675 tons per mon

Vidhi Specialty Food Ingredients LtdQ4 FY24Chemicals & Petrochemicals

Vidhi Specialty Food Ingredients Ltd Q4 FY24 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹311.85P/E: 29.0Market Cap: ₹1.6K CrSector: Chemicals & Petrochemicals

Management growth scorecard

Revenue

Category 2

Margin

Category 1

Fundraise

N/A

Order

Yes

Capex

Yes

3 of 4 growth signals are positive.

Full analysis

Revenue guidance

Category 2

FY24 manufacturing volume stood at 3,800 metric tons; FY25 volume guidance is around 4,600-4,800 metric tons, indicating growth.
By end of FY25, the run rate at full utilization is expected to be ~675 tons per month (vs current ~540 tons).
Dahej SEZ plant capacity ramp-up to full utilization by Q3 FY25, contributing significantly to volumes and revenue.
New high value, high margin products currently contributing ~15% of volume and potentially >30% of revenue, expected to grow.
Expected average selling price per kilo to improve by more than 10% with new products and portfolio enhancement.
EBITDA margins are forecasted to expand by another 400-500 bps as Dahej facility utilization improves and higher value products ramp up.
Domestic sales, though currently small, are anticipated to grow robustly alongside exports.
Order book visibility extends into FY26, supporting confidence in growth trajectory.

Margin guidance

Category 1

Company expects EBITDA margins to improve by another 400-600 basis points with full ramp-up of Dahej facility and new high-margin products.
Manufacturing EBITDA margins have already improved by approx. 500 basis points from FY23 to FY24.
Peak revenue potential from Dahej SEZ is INR250-300 crores.
New products (high-value, high-margin) may contribute around 15% of volume but over 30% of revenue, boosting margins.
Operating profits expected to rise as trading revenues decline and manufacturing revenues increase.
By end of FY25, capacity utilization expected to reach 675 tons per month across all plants, supporting volume growth.
Net profit growth in FY24 was slightly down due to higher depreciation from Dahej startup but expected to improve with operational scale-up.
Overall, the company foresees strong profit growth driven by capacity expansion, better product mix, and operational efficiencies.

See what Vidhi Specialty Food Ingredients Ltd management said on margin guidance — free account, 30 seconds.

Fundraise plans

There is no mention of any new fundraising through debt or equity in the provided transcript.
The company highlights a strong financial position, with current assets of INR187 crores against current liabilities of INR39 crores as of FY24.
The INR70 crores expansion was fully funded through internal accruals, indicating no external fundraising.
Bank limit utilization has decreased significantly from INR50.50 crores to INR19.43 crores by March 2024, showing reduced reliance on borrowings.
For the upcoming Roha expansion, an estimated INR40-50 crores capex is expected, which will also be funded entirely through internal accruals.
The company describes itself as cash surplus with no issues in funding capex from existing resources.
No indications of plans for equity issuance or new debt raising were disclosed during the call.

Order book

Yes

The company has a strong order book with executable visibility going into FY '26.
Existing order book allows full utilization of current and expanded production capacities, including the new Dahej SEZ plant.
Additional approvals from very large accounts are at advanced stages, expected to be finalized in the coming months.
Demand pipeline is robust, supporting confidence in ramping up capacity and pursuing a third expansion in Roha.
The company is confident of meeting market demand and achieving full production utilization by end of FY '25, with an expected run rate of 675 tons per month across all plants.

See what Vidhi Specialty Food Ingredients Ltd management said on order book — free account, 30 seconds.

Capex plans

Yes

- Dahej SEZ plant expansion completed with INR70 crores capex, fully funded through internal accruals. - Awaiting environmental clearance for greenfield expansion at Roha; infrastructure largely ready. - Expected capex for Roha expansion is around INR40-50 crores, to be funded through internal accruals. - No specific timeline provided yet for Roha expansion start until environmental approvals obtained. - Management currently refraining from forward guidance on further Roha expansion until approvals are clear. - Trading business being exited; no capex on trading side. - Focus on adding new high-value, high-margin products in new facilities, driving margin improvement. Overall, current capex focuses mainly on Roha greenfield expansion post environmental clearance, with Dahej expansion recently commissioned.

Track Vidhi Specialty Food Ingredients Ltd — get its next earnings analysis in your feed

How does Vidhi Specialty Food Ingredients Ltd rank vs peers in Chemicals & Petrochemicals?

Pro feature

ThisVidhi Specialty Food Ingredients Ltd

Rev 2Mar 1

See where Vidhi Specialty Food Ingredients Ltd sits in Chemicals & PetrochemicalsSee which companies these are, and every other name in the sector.Open rankings

How does Vidhi Specialty Food Ingredients Ltd rank in Chemicals & Petrochemicals?

Compare Vidhi Specialty Food Ingredients Ltd against every Chemicals & Petrochemicals company (Q4 FY24) on revenue, margins and earnings-call signals.

View Chemicals & Petrochemicals leaderboard →

What Vidhi Specialty Food Ingredients Ltd's management said in earlier quarters

Others in Chemicals & Petrochemicals this season

POCL Enterprises Ltd (Q1 FY27)
466.03 crores (Page 12, 17, 11) . Key investor presentation takeaways from POCL Enterprises Ltd's Q1 FY27 investor presentation — and how it ranks against secto
Deepak Nitrite Ltd (Q2 FY27)
Q2 FY27 total revenue: ₹3,091 crore, up 61% YoY (Page 1, 4, 5, 6, 10, 11) . Key investor presentation takeaways from Deepak Nitrite Ltd's Q2 FY27 investor prese
Privi Speciality Chemicals Ltd (Q2 FY27)
19,239.47 lakhs (approximately 33.9% growth). Key results statement takeaways from Privi Speciality Chemicals Ltd's Q2 FY27 results statement — and how it ranks
NOCIL Ltd (Q2 FY27)
427 crores . Key investor presentation takeaways from NOCIL Ltd's Q2 FY27 investor presentation — and how it ranks against sector peers.

Compare:vs Solar Industries vs Pidilite Inds.vs SRF Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →